COMMUNIQUÉS West-GlobeNewswire

Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
13/01/2026
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced the [...]
Aqua free enters the B2C market with “Shower2go”: a portable travel shower for safer showering on the go – helping to reduce exposure to Legionella
13/01/2026
Hamburg, 12.01.2025 – Aqua free , a leading European provider of drinking-water hygiene solutions, is launching Shower2go, a portable travel shower for consumers. Designed for hotels, holiday rentals, campsite washrooms [...]
Synfini Assessed ‘Awardable’ for DARPA ERIS Marketplace
13/01/2026
MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Synfini , a leading provider of the industry’s most innovative Agile AI Foundry for drug discovery, today announced that it has achieved “Awardable” status through [...]
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
13/01/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 13, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
13/01/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 13 janvier 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2025
13/01/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
13/01/2026
Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
La FDA américaine accorde la désignation « Breakthrough Therapy » à l’IPN60340 (ICT01) d’Ipsen dans la leucémie myéloïde aiguë de première ligne chez les patients inéligibles à une chimiothérapie intensive
13/01/2026
La désignation « Breakthrough Therapy » a été accordée pour la thérapie expérimentale IPN60340 en association avec le vénétoclax et l’azacitidine dans la leucémie myéloïde aiguë de première ligne chez les patients [...]
U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
13/01/2026
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia PARIS, FRANCE, 13 JANUARY 2026 - Ipsen (Euronext: [...]
SPINEWAY : Chiffre d’affaires annuel 2025 de 12,4 ME avec une accélération des ventes au T4 2025 (+34%)
13/01/2026
Ecully, le 13 janvier 2026 – 18h30 SPINEWAY Chiffre d’affaires annuel 2025 de 12,4 M€ avec une accélération des ventes au T4 2025 (+34%) En milliers d’euros 2025 2024 Variation en % CA 1 er semestre 5 573 6 535 - 15% CA [...]
SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
13/01/2026
Ecully, January 13, 2026 – 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros 2025 2024 Change as a % H1 revenue 5,573 6,535 -15% H2 revenue 6,857 5, [...]
Metabo Drops Examined: Is It Legit for Weight Loss? Safety Checks and Consumer Analysis 2026
13/01/2026
New York, NY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Consumer interest in supplement legitimacy continues to rise as transparency becomes a deciding factor in purchasing decisions. Searches that include phrases such as “Is [...]
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
13/01/2026
VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced unaudited [...]
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
13/01/2026
Fourth quarter results represent highest quarterly revenue in Company’s history Q4 year-over-year growth of 35% to 39% driven by sales execution of Ameluz ® Full year 2025 revenues also expected to show double-digit [...]
Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change
13/01/2026
BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products [...]
NetraMark Announces Private Placement Financing
13/01/2026
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials [...]
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
13/01/2026
The minimally dilutive funding will accelerate Pelthos’ highly successful commercialization efforts for its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3% for the treatment of molluscum contagiosum, two newly [...]
LifeRx Formally Launches Nationwide ED & Hair Loss Treatment Programs After Strong Early Traction
13/01/2026
Cherry Hill, NJ, Jan. 13, 2026 (GLOBE NEWSWIRE) -- LifeRx, a trusted telehealth and wellness company specializing in metabolic, hormonal, cellular, performance, and men's health, today announces the formal national [...]
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
13/01/2026
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system FORT LAUDERDALE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS [...]

Pages